This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0613U only for AssureMDxTM from Vesica Health® Inc. This test evaluates urine for DNA changes in six biomarkers using methylation–specific polymerase chain reaction (PCR) and targeted next–generation sequencing (NGS). An algorithm combines these results to produce a probability index that indicates the likelihood of bladder cancer or upper tract urothelial carcinoma.
For clinical responsibility, terminology, tips and additional info
start codify free trial.